These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 37633929)

  • 41. Mass spectrometry-based proteomics: a useful tool for biomarker discovery?
    Gramolini AO; Peterman SM; Kislinger T
    Clin Pharmacol Ther; 2008 May; 83(5):758-60. PubMed ID: 18388886
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The evolving role of mass spectrometry in cancer biomarker discovery.
    Wang P; Whiteaker JR; Paulovich AG
    Cancer Biol Ther; 2009 Jun; 8(12):1083-94. PubMed ID: 19502776
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sample Treatment for Tissue Proteomics in Cancer, Toxicology, and Forensics.
    Cole LM; Clench MR; Francese S
    Adv Exp Med Biol; 2019; 1073():77-123. PubMed ID: 31236840
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proteomics: the next revolution in laboratory medicine?
    Plebani M
    Clin Chim Acta; 2005 Jul; 357(2):113-22. PubMed ID: 15941565
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serum proteomics in multiple sclerosis disease progression.
    Tremlett H; Dai DL; Hollander Z; Kapanen A; Aziz T; Wilson-McManus JE; Tebbutt SJ; Borchers CH; Oger J; Cohen Freue GV
    J Proteomics; 2015 Apr; 118():2-11. PubMed ID: 25753122
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Implementation of CE-MS-identified proteome-based biomarker panels in drug development and patient management.
    Stepczynska A; Schanstra JP; Mischak H
    Bioanalysis; 2016; 8(5):439-55. PubMed ID: 26891752
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Application of machine learning to proteomics data: classification and biomarker identification in postgenomics biology.
    Swan AL; Mobasheri A; Allaway D; Liddell S; Bacardit J
    OMICS; 2013 Dec; 17(12):595-610. PubMed ID: 24116388
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer's Disease.
    Robinson RA; Amin B; Guest PC
    Adv Exp Med Biol; 2017; 974():21-48. PubMed ID: 28353223
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The application of mass spectrometry to proteomics and metabolomics in biomarker discovery and drug development.
    Mikami T; Aoki M; Kimura T
    Curr Mol Pharmacol; 2012 Jun; 5(2):301-16. PubMed ID: 22122469
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications.
    de Wit M; Fijneman RJ; Verheul HM; Meijer GA; Jimenez CR
    Clin Biochem; 2013 Apr; 46(6):466-79. PubMed ID: 23159294
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mass spectrometry-based proteomics in biomedical research: emerging technologies and future strategies.
    Walsh GM; Rogalski JC; Klockenbusch C; Kast J
    Expert Rev Mol Med; 2010 Sep; 12():e30. PubMed ID: 20860882
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prospective applications of ultrahigh resolution proteomics in clinical mass spectrometry.
    Ruhaak LR; van der Burgt YE; Cobbaert CM
    Expert Rev Proteomics; 2016 Dec; 13(12):1063-1071. PubMed ID: 27798968
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analytical techniques for multiplex analysis of protein biomarkers.
    Van Gool A; Corrales F; Čolović M; Krstić D; Oliver-Martos B; Martínez-Cáceres E; Jakasa I; Gajski G; Brun V; Kyriacou K; Burzynska-Pedziwiatr I; Wozniak LA; Nierkens S; Pascual García C; Katrlik J; Bojic-Trbojevic Z; Vacek J; Llorente A; Antohe F; Suica V; Suarez G; t'Kindt R; Martin P; Penque D; Martins IL; Bodoki E; Iacob BC; Aydindogan E; Timur S; Allinson J; Sutton C; Luider T; Wittfooth S; Sammar M
    Expert Rev Proteomics; 2020 Apr; 17(4):257-273. PubMed ID: 32427033
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Perspectives for imaging mass spectrometry in the proteomics landscape.
    MacAleese L; Stauber J; Heeren RM
    Proteomics; 2009 Feb; 9(4):819-34. PubMed ID: 19212956
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A review on mass spectrometry-based quantitative proteomics: Targeted and data independent acquisition.
    Vidova V; Spacil Z
    Anal Chim Acta; 2017 Apr; 964():7-23. PubMed ID: 28351641
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mass spectrometry analysis of glycoprotein biomarkers in human blood of hepatocellular carcinoma.
    Kim KH; Kim JY; Yoo JS
    Expert Rev Proteomics; 2019 Jul; 16(7):553-568. PubMed ID: 31145639
    [No Abstract]   [Full Text] [Related]  

  • 57. Matrix-assisted laser desorption ionisation (MALDI) mass spectrometry (MS): basics and clinical applications.
    Israr MZ; Bernieh D; Salzano A; Cassambai S; Yazaki Y; Suzuki T
    Clin Chem Lab Med; 2020 Jun; 58(6):883-896. PubMed ID: 32229653
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advances in mass spectrometry-based cancer research and analysis: from cancer proteomics to clinical diagnostics.
    Timms JF; Hale OJ; Cramer R
    Expert Rev Proteomics; 2016 Jun; 13(6):593-607. PubMed ID: 27109265
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Application of mass spectrometry-based proteomics for biomarker discovery in neurological disorders.
    Venugopal A; Chaerkady R; Pandey A
    Ann Indian Acad Neurol; 2009 Jan; 12(1):3-11. PubMed ID: 20151002
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer.
    Whiteaker JR; Zhang H; Zhao L; Wang P; Kelly-Spratt KS; Ivey RG; Piening BD; Feng LC; Kasarda E; Gurley KE; Eng JK; Chodosh LA; Kemp CJ; McIntosh MW; Paulovich AG
    J Proteome Res; 2007 Oct; 6(10):3962-75. PubMed ID: 17711321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.